breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient is female, aged = 18 years; 2. ECOG score 0-1; 3. It is confirmed by pathology as unilateral or bilateral primary invasive carcinoma of the breast; 4. Immunohistochemistry (IHC) showed that the expression of ER or/and PR was low (1-20%) and HER-2 was negative; 5. According to the current AJCC breast cancer staging standards, the researchers have evaluated the patients as I-III based on radiology and/or clinical evaluation; 6. The patient has undergone modified radical mastectomy or breast conserving radical mastectomy for breast cancer. After surgery, ddEC-TP scheme was used as adjuvant chemotherapy, and chemotherapy has ended.
Exclusion criteria
Exclusion criteria: 1. Distant metastasis of breast cancer at any location (stage IV); 2. After mastectomy or minimally invasive rotary resection; 3. Have received endocrine therapy or castration therapy in the past; 4. Incomplete baseline information or immunohistochemical results; 5. Have a history of other malignant tumors; 6. Patients with severe cardiac insufficiency, liver and kidney insufficiency, active mental system diseases (schizophrenia, severe depression, bipolar disorder, etc.); 7. Not willing to sign the informed consent form; 8. Persons without full civil capacity; 9. In the opinion of the researchers, other conditions make them unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival; | — |
Countries
China
Contacts
The third Department of breast surgery, Yunnan Cancer Hospital